Oral lichen planus following the administration of vector-based COVID-19 vaccine (Ad26.COV2.S)

被引：37
|
作者：
Troeltzsch, Matthias [1 ,2 ]
Gogl, Markus [2 ]
Berndt, Ronald [3 ]
Troeltzsch, Markus [2 ]
机构：
[1] Ludwig Maximilians Univ Munchen, Univ Hosp, Dept Oral & Maxillofacial Surg & Facial Plast Sur, Lindwurmstr 2a, D-80337 Munich, Germany
[2] Ctr Oral Maxillofacial & Facial Reconstruct Surg, Ansbach, Germany
[3] Ansbach Gen Hosp, Dept Pathol, Ansbach, Germany
来源：
ORAL DISEASES | 2022年 / 28卷
关键词：
Ad26.COV2.S; COVID vaccine; COVID-19; oral lichen planus;
D O I：
10.1111/odi.14025
中图分类号：
R78 [口腔科学];
学科分类号：
1003 ;
摘要：
引用
收藏
页码：2595 / 2596
页数：2
相关论文
共 50 条
  • [21] Association of Ad26.COV2.S COVID-19 Vaccine With Presumptive Guillain-Barre Syndrome Reply
    Woo, Emily Jane
    Dimova, Rositsa B.
    Mba-Jonas, Adamma
    JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2022, 327 (04): : 393 - 394
  • [22] Ad26.COV2.S COVID-19 Vaccine Safety And Immunogenicity in Adolescents 16-17 Years of Age
    Ruiz-Guinazu, Javier
    Le Gars, Mathieu
    Cardenas, Vicky
    Vaissiere, Nathalie
    Sadoff, Jerald
    Truyers, Carla
    Hendriks, Jenny
    Scheper, Gert
    de Groot, A. Marit
    Struyf, Frank
    Schuitemaker, Hanneke
    Douoguih, Macaya
    JOURNAL OF THE PEDIATRIC INFECTIOUS DISEASES SOCIETY, 2024, 13 (11) : 599 - 601
  • [23] Use of Janssen Ad26.COV2.S COVID-19 vaccine (JCOVDEN) and mRNA COVID-19 vaccines in four large US national insurers
    Mayer, Sophie E.
    Fuller, Candace C.
    Haynes, Kevin
    Alam, Sarah
    Brown, Jeffrey
    Daniels, Kimberly M.
    Hawrusik, Rebecca
    Horgan, Casie E.
    Jamal-Allial, Aziza
    Johannes, Catherine B.
    Kawai, Alison Tse
    Layton, J. Bradley
    Mai, Xiaodan
    Marshall, James
    McMahill-Walraven, Cheryl N.
    Reynolds, Juliane S.
    Seals, Ryan M.
    Selvan, Mano
    Stemkowski, Stephen A.
    Wang, Florence
    Yost, Emily
    Gilsenan, Alicia W.
    Platt, Richard
    PHARMACOEPIDEMIOLOGY AND DRUG SAFETY, 2023, 32 : 186 - 186
  • [24] Guillain-Barre Syndrome Following the Administration of Adenovirus Vector-Based COVID-19 Vaccine
    Lee, Mardy L.
    Bautista, Juan Miguel P.
    CUREUS JOURNAL OF MEDICAL SCIENCE, 2023, 15 (07)
  • [25] Myocarditis following rAd26 and rAd5 vector-based COVID-19 vaccine
    Mungmunpuntipantip, Rujittika
    Wiwanitkit, Viroj
    ESC HEART FAILURE, 2022, 9 (03): : 2053 - 2053
  • [26] Efficacy of Single-Dose Ad26.COV2.S Vaccine against Covid-19-Reply
    Vandebosch, An
    Sadoff, Jerald
    Douoguih, Macaya
    NEW ENGLAND JOURNAL OF MEDICINE, 2021,
  • [27] Oral lichen planus following mRNA COVID-19 vaccination
    Kaomongkolgit, Ruchadaporn
    Sawangarun, Wanlada
    ORAL DISEASES, 2022, 28 : 2622 - 2623
  • [28] Immunogenicity Following Administration of BNT162b2 and Ad26.COV2.S COVID-19 Vaccines in the Pregnant Population during the Third Trimester
    Citu, Ioana Mihaela
    Citu, Cosmin
    Gorun, Florin
    Sas, Ioan
    Tomescu, Larisa
    Neamtu, Radu
    Motoc, Andrei
    Gorun, Oana Maria
    Burlea, Bogdan
    Bratosin, Felix
    Malita, Daniel
    VIRUSES-BASEL, 2022, 14 (02):
  • [29] Comparative Effectiveness of mRNA-based BNT162b2 Vaccine versus Adenovirus Vector?Based Ad26.COV2.S Vaccine for the Prevention of COVID-19 among Dialysis Patients
    Brunelli, Steven M.
    Sibbel, Scott
    Karpinski, Steph
    Marlowe, Gilbert
    Walker, Adam G.
    Giullian, Jeffrey
    Van Wyck, David
    Kelley, Tara
    Lazar, Rachael
    Zywno, Meredith L.
    Connaire, Jeffrey J.
    Young, Amy
    Tentori, Francesca
    JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY, 2022, 33 (04): : 688 - 697
  • [30] mRNA COVID-19 vaccine and oral lichen planus: A case report
    Caggiano, Mario
    Amato, Massimo
    Di Spirito, Federica
    Galdi, Marzio
    Sisalli, Laura
    ORAL DISEASES, 2022, 28 : 2624 - 2626
12345